Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

The internet-of-things security software provider increased its funding to $45m altogether, with Dell, NTT Docomo and MS&AD Holdings all investing in the series B round.

SBI Investment led a $17.2m round that will enable the online healthcare platform developer to expand its hospital network in India.

Shin Nippon Biomedical Laboratories was among the investors in its spinoff, which is working on treatments for acute migraine.

GV, ServiceNow Ventures and IVP co-led the series B round, which valued the AI-based software testing and deployment platform at $500m.

Slack Fund has taken part in a $15.5m series B round that increased the AI-based enterprise software developer's total funding to $27m.

Osage University Partners has participated in a $62m series B round for Satsuma Pharmaceuticals, which also featured Shin Nippon Biomedical Laboratories.

SoftBank Ventures Asia led a series B round that boosted the AI-based marketing software provider's total funding to $30m.

The bookkeeping service provider increased its total funding to almost $59m with a Stripe-backed round that will support product development.

Celgene and Pfizer returned for small molecule drug developer Arrakis Therapeutics' latest round, which included GV and Wuxi AppTec Fund.